XML 40 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues $ 323 $ 538
Cost of revenues 441 355
Gross profit (loss) (118) 183
Operating expenses:    
Research and development 28,858 18,234
Selling, general and administrative 61,701 42,668
Total operating expenses 90,559 60,902
Operating loss (90,677) (60,719)
Other income (expense):    
Other income 1,482 17
Interest expense (1,484) (465)
Extinguishment of debt   (181)
Change in estimated fair value of earn-out liabilities 82,734  
Total other income (expense) 82,732 (629)
Loss before income taxes (7,945) (61,348)
Income tax expense (19)  
Net loss (7,964) (61,348)
Unrealized loss on short-term investments (21)  
Comprehensive loss (7,985) (61,348)
Net loss (7,964) (61,348)
Dividends on Series D convertible preferred stock (7,383) (6,660)
Redemption value of Series D convertible preferred stock (3,692) (58,649)
Net loss attributable to common stockholders - basic $ (19,039) $ (126,657)
Net loss per share attributable to common stockholders - basic $ (0.64) $ (91.88)
Net loss per share attributable to common stockholders - diluted $ (0.64) $ (91.88)
Weighted average common stock outstanding - basic 29,878,041 1,378,527
Weighted average common shares outstanding - diluted 29,878,041 1,378,527